EyeC
The computed 12-month bankruptcy probability of EyeC is 0.2% (very low). The 2025 annual accounts show equity of €155k and a net result of €73k. Its solvency ranks better than 82% of 2198 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €155k |
| Net result | €73k |
| Better than sector | 82% |
| Active | 3 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 87.4% | 58.0% | |
| Net result | €73k | €60k | |
| Equity | €155k | €74k | |
| Gross operating margin | €94k | €96k | |
| Total assets | €177k | €187k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €94k |
| Net profit | €73k |
| Cash flow | €75k |
| Staff costs | - |
| Income taxes | €19k |
| Dividends | - |
| Total assets | €177k |
| Equity | €155k |
| Debt | €22k |
| of which ≤ 1y | €20k |
| of which > 1y | - |
| Working capital | €154k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 8.75 |
| Quick ratio | 8.75 |
| Working capital ratio | 86.8% |
| Solvency | 87.4% |
| Debt / equity | 0.14 |
| Long-term debt ratio | - |
| Interest coverage | 53.92 |
| Gross margin | - |
| Net margin | - |
| ROA | 41.2% |
| ROE | 47.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €177k |
| Fixed assets | 21/28 | €4k |
| Intangible fixed assets | 21 | €1k |
| Tangible fixed assets | 22/27 | €2k |
| Current assets | 29/58 | €174k |
| Amounts receivable within one year | 40/41 | €5k |
| Cash & bank | 54/58 | €165k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €177k |
| Equity | 10/15 | €155k |
| Contributions / capital | 10/11 | €4k |
| Reserves | 13 | €151k |
| Amounts payable | 17/49 | €22k |
| Amounts payable within one year | 42/48 | €20k |
| Income statement | ||
| Gross operating margin | 9900 | €94k |
| Operating result | 9901 | €92k |
| Financial income | 75 | €2k |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €92k |
| Income taxes | 67/77 | €19k |
| Net result for the period | 9904 | €73k |
| Result to be appropriated | 9905 | €73k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 09-05-2023 |
| Status | Active |
| Postal code | 1500 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23027G0625/00G000 | Flanders | 1,426 m² | 1 · 1,106 m² | 12.6 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | EyeC |